
D3 Bio, a global biotechnology company, has raised $200 million in Series A financing. The investors included Boyu Capital, Matrix Partners China, Sequoia Capital China, Temasek, and WuXi AppTec.
Source: Press Release
D3 Bio, a global biotechnology company, has raised $200 million in Series A financing.
D3 Bio, a global biotechnology company, has raised $200 million in Series A financing. The investors included Boyu Capital, Matrix Partners China, Sequoia Capital China, Temasek, and WuXi AppTec.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination